Ninety-five geriatric patients with osteoarthritis of the hip and/or knee were entered into an open parallel group study of sulindac (400 mg/day) and naproxen (500 mg/day), both given in twice-daily regimens. Patients received the drugs for 12 weeks. Both drugs produced improvements in the patients' overall condition. There were no statistically significant differences between the effects of the two drugs. Overall, both drugs proved beneficial and well tolerated.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
study sulindac
8
multi-centre study
4
sulindac versus
4
versus naproxen
4
naproxen treatment
4
treatment elderly
4
elderly osteoarthritic
4
osteoarthritic patients
4
patients ninety-five
4
ninety-five geriatric
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!